Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?
Vollebregt AAM, Ebbink BJ, Rizopoulos D, Lequin MH, Aarsen FK, Shapiro EG, van der Ploeg AT, van den Hout JMP. Vollebregt AAM, et al. J Inherit Metab Dis. 2021 May;44(3):751-762. doi: 10.1002/jimd.12342. Epub 2021 Jan 25. J Inherit Metab Dis. 2021. PMID: 33330992 Free PMC article.
OBJECTIVE: To advance the prediction of the neurocognitive development in MPS II patients by jointly analyzing MRI and neurocognitive data in mucopolysaccharidosis (MPS) II patients. ...
OBJECTIVE: To advance the prediction of the neurocognitive development in MPS II patients by jointly analyzing MRI and neurocognitive …
Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II.
Vedolin L, Schwartz IV, Komlos M, Schuch A, Puga AC, Pinto LL, Pires AP, Giugliani R. Vedolin L, et al. AJNR Am J Neuroradiol. 2007 Jun-Jul;28(6):1029-33. doi: 10.3174/ajnr.A0510. AJNR Am J Neuroradiol. 2007. PMID: 17569950 Free PMC article.
BACKGROUND AND PURPOSE: There are no reliable markers to predict neurologic outcome of patients with mucopolysaccharidosis (MPS) II. ...
BACKGROUND AND PURPOSE: There are no reliable markers to predict neurologic outcome of patients with mucopolysaccharidosis (MPS) II. …